Key takeaways
Tirzepatide can be a powerful tool for people embarking on a weight loss journey. In clinical trials, the drug caused up to about 20% weight loss on average in a year and a half.
Tirzepatide slows down digestion, reduces food noise, and acts on brain receptors that regulate your appetite, all of which make it highly effective at reducing body weight.
Tirzepatide mimics two gut hormones naturally produced in your body, which makes it more effective at both weight loss and blood sugar control than other GLP-1 medications that mimic a single hormone.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
Tirzepatide can be a powerful tool for people embarking on a weight loss journey. In clinical trials, the drug caused up to about 20% weight loss on average in a year and a half.
Tirzepatide slows down digestion, reduces food noise, and acts on brain receptors that regulate your appetite, all of which make it highly effective at reducing body weight.
Tirzepatide mimics two gut hormones naturally produced in your body, which makes it more effective at both weight loss and blood sugar control than other GLP-1 medications that mimic a single hormone.
Tirzepatide is the active ingredient in the prescription diabetes and weight loss medications Mounjaro and Zepbound. It primarily works by slowing down gastric emptying, reducing “food noise,” and balancing blood sugar. In clinical trials of people with obesity, tirzepatide led to an average weight loss of up to 20.9% in about a year and a half. Read on to learn more.
How well does tirzepatide work for weight loss?
“For weight loss, tirzepatide slows gastric emptying, which slows down the passage of food in your stomach,” says Peminda K. Cabandugama, MD, a board-certified physician in obesity and endocrinology and Clinical Associate Professor of Medicine at the Cleveland Clinic.
“If food is in your stomach longer, you'll be full longer and less hungry. Patients tell me that it also calms down food noise. Researchers think it affects the hypothalamus where our cravings come from,” Dr. Cabandugama says.
Here’s how tirzepatide works in your body:
Appetite control: It targets two hormone receptors in areas of your brain that control hunger: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Together, this turns down your appetite and reduces intrusive thoughts about food, often called "food noise".
Slower digestion: It delays gastric emptying, aka how fast food leaves your stomach. This physical fullness keeps you feeling satisfied much longer after a small meal.
Blood sugar balance: It helps your pancreas release insulin properly after you eat and stops your liver from making extra, unneeded sugar. This steady blood sugar prevents the sharp crashes that normally trigger sudden hunger.
Tirzepatide can cause significant weight loss, according to clinical studies. Trial participants with obesity or overweight lost an average of about 15% of their body weight with the 5 mg dose, 19.5% with 10 mg, and 21% with 15 mg in 72 weeks (about a year and a half).
An analysis of ten studies found that people taking tirzepatide lost more weight, on average, than those taking other weight loss or diabetes medications. They lost 21.6 more pounds on average than those taking a placebo, 4.3 more pounds than those taking insulin, and 2.3 more pounds than those taking other GLP-1 medications.
The studies ranged in duration from 12 to 72 weeks, and the participants in all but one of the studies had type 2 diabetes.
In a separate trial of people with type 2 diabetes, tirzepatide led to an average weight loss of 12.8%–14.7% on the two highest doses of Mounjaro. In another study comparing Mounjaro vs. Ozempic, those taking tirzepatide 15 mg weekly lost 9.7% more body fat in seven months. Those taking Ozempic 1 mg weekly, on the other hand, lost just under 6%.
How long does it take for tirzepatide to work?
Tirzepatide starts working as soon as you take it, but it takes about four weeks before it reaches a steady concentration in your bloodstream. It’s around this point that people usually start to notice weight loss.
From a diabetes management perspective, clinical trials of Mounjaro showed meaningful improvements in hemoglobin A1c (HbA1c) within about three months. The effect on blood sugar readings may appear sooner, but A1c takes longer to reflect the change because it measures average blood sugar levels over the past two to three months.
By three months, average HbA1c levels dropped to prediabetes levels (6.4%) or lower. And at the end of this 40-week study, HbA1c levels had dropped by 2%–2.3%, and the average body weight reduction was 7.6%–11.2%.
Does tirzepatide get rid of belly fat?
Belly fat, or the fat stored in the abdomen, is often where many people on a weight loss journey want to see the most improvement. But can tirzepatide actually help you get rid of belly fat?
“I get asked this by patients all the time,” says Dr. Cabandugama. “They’ll ask me, ‘Can you reduce the size of my belly (or breasts or thighs)?’ I tell them that is [only possible with] plastic surgery. Tirzepatide will help you lose weight, but weight can come from all different places.”
While it’s not possible to target your fat loss to a specific area (without plastic surgery), it’s likely that someone on tirzepatide will lose belly fat while reducing their overall body fat (participants in one clinical trial lost on average 7 inches from their waist).
How to maximize weight loss on tirzepatide
When it comes to maximizing weight loss on tirzepatide, the most important things are implementing healthy diet and exercise changes, and finding the right healthcare team. They can help you determine the right dosage for you and guide you toward the best results.
1. Find the right dosage of tirzepatide for you
It’s important to make sure you find the right dose for your body, Dr. Cabandugama says. While there is a standard dosage schedule, not everyone will benefit from the same titration.
A modified dose-escalation schedule, while considered off-label since it is not the same as the manufacturer’s instructions, may be recommended by your medical team depending on your goals and side effects.
“The FDA did approve these medications’ doses to be increased every four weeks but you’ll see most of the folks who experience weight loss will not increase every four weeks unless they have to,” he says.
“It’s not a race to get to the top dose; it’s about maximizing each dose of the medication,” he adds. “See a healthcare provider who will follow you closely to make sure you're doing well.”
2. Improve your diet and exercise routine
Tirzepatide works best when combined with lifestyle changes like a healthy diet and regular exercise. Certain foods can worsen tirzepatide’s side effects and hinder weight loss results, including heavy meals and fatty, fried, or ultra-processed foods.
“See a dietitian or nutritionist to make sure you're maximizing your diet and getting enough protein intake, which is a building block for hair and nails,” says Dr. Cabandugama. “We’re not trying to stop you from eating; it’s about helping you go back to healthier choices when eating, and experience [fewer] cravings.”
To lose weight, it is important to eat less, but maintaining that weight loss requires regular exercise. According to Dr. Cabandugama, research consistently supports the importance of physical activity in sustaining long-term results, with guidelines recommending at least 150 minutes of exercise per week.
Try to find a routine that works for you, whether it’s 1.5 hours a day on the weekend or 30 minutes a day throughout the week
3. Expand your healthcare team
Having a comprehensive approach to weight loss can maximize your results on tirzepatide. In addition to your prescribing practitioner, you may want to meet with other healthcare providers as well, such as a dietitian and, if needed, a plastic surgeon.
“When patients lose a bunch of weight, they start to get loose or excess skin, which has its own weight, so having a multidisciplinary approach where you can get rid of that excess skin is also helpful,” says Dr. Cabandugama.
Questions to ask your provider about tirzepatide for weight loss
Here are some questions you may want to ask your healthcare provider when you meet with them to discuss taking tirzepatide for weight loss.
Is tirzepatide a good option for me based on my medical history, current health conditions, and weight loss goals?
What kind of results should I realistically expect when taking tirzepatide for weight loss?
How does tirzepatide compare to other weight loss medications?
What is the appropriate starting dose for me, and how will my dose be adjusted over time?
How long should I expect to take tirzepatide?
What are the potential side effects of tirzepatide, and how common are they? How do I know when a side effect is normal vs. potentially serious?
Are there any long-term risks associated with using tirzepatide for weight loss?
Will tirzepatide interact with any other prescription or over-the-counter medicines I’m currently taking?
Do I need to follow a specific diet or exercise plan while taking tirzepatide?
How will my progress be monitored while I’m on tirzepatide?
What signs or symptoms should I look for that might indicate a problem or the need to adjust my treatment?
Is tirzepatide covered by my insurance plan, and what are the out-of-pocket costs?
Are there patient assistance programs or discounts available for tirzepatide?
If tirzepatide doesn’t work for me, what other options do you recommend?
How to take tirzepatide
How you take tirzepatide depends on whether your medication comes in a prefilled pen or in a vial.
How to inject a tirzepatide pen
Here’s how to inject a tirzepatide pen, using the US Food and Drug Administration (FDA)’s instructions for the Zepbound KwikPen and the Mounjaro KwikPen. Be sure to follow the instructions that come with your medication, as the steps differ for single-dose pens.
1. Wash your hands thoroughly with soap and water.
2. Inspect the pen. Confirm that you have the right dose and that the medication has not expired. The medicine should be clear and colorless (or slightly yellow). If it is frozen, cloudy, or contains particles, dispose of the pen and use a new one.
3. Pull off the cap and wipe the red inner seal with an alcohol swab.
4. Select your pen needle and pull the paper tab off of the needle shield. Then, push the capped needle into the pen, twisting it until it’s on tight. Pull off the outer needle shield. (Hold on to this — you’ll need it again). Then, take off the inner needle shield and throw it out.
5. Prime the KwikPen by turning the dose knob until you hear 2 clicks. Hold the pen with the needle pointing up, then gently tap the cartridge so any air bubbles go to the top. Next, push the dose knob in slowly until it stops, and then count to 5 while holding the dose knob. This should release a bit of the medicine into the air.
6. Choose your injection site. It can be the back of your upper arm if someone is helping you, or if you’re self-injecting, you can choose the front or outer side of your thigh, or anywhere on your abdomen at least two inches away from your belly button. Be sure to rotate injection sites, choosing a spot that’s at least one finger’s width away from where you last injected tirzepatide. Avoid areas with scars, rashes, or bruises.
7. Turn the knob on the pen until it stops and the “1” icon is in the dose window.
8. Insert the needle straight into your skin. Push the dose knob in until it stops. Count to 5 slowly while holding the dose knob. Make sure the “0” icon is showing before you pull the needle out of your skin.
9. If there’s any blood at the injection site, apply gentle pressure with gauze or a cotton ball.
10. Replace the outer needle shield and then unscrew the capped needle. Put the needle into a sharps container.
11. Replace the pen cap and store it safely for next week.
How to inject tirzepatide from a vial
If your tirzepatide comes in a vial, follow these steps to inject it:
1. Wash your hands thoroughly with soap and water.
2. Remove the vial from the refrigerator and gather your sterile syringe with a needle and two alcohol wipes.
3. Inspect the vial. Confirm that you have the right dose and that the medication has not expired. The medicine should be clear and colorless (or slightly yellow). If it is frozen, cloudy, or contains particles, do not use it.
4. Shake and clean the vial. Pull off the plastic cap, but keep the rubber stopper in place. Clean the top of the rubber stopper with one of your alcohol wipes.
5. Remove the caps from the plunger and the needle. Do not touch the needle while you do this, so things stay sterile.
6. Hold the syringe with the needle pointing up. Pull down the plunger to fill the needle with air up to the 0.5 mL line.
7. Place the vial on a flat surface and insert the needle into the vial. Push down to inject all of the air into the vial.
8. With the needle still inside the vial, turn the vial upside down. The needle tip should be surrounded by liquid.
9. Pull the plunger just past the 0.5 mL line.
10. Flick the syringe with your finger to remove any air bubbles.
11. Push the plunger back up to the 0.5 mL line.
12. Remove the syringe from the vial and apply a new seal sticker to the cap of the vial.
13. Choose your injection site. It can be the back of your upper arm (if someone’s helping you), the front or outer side of your thigh, or anywhere on your abdomen at least two inches away from your belly button. Choose a spot that’s at least one finger’s width away from where you last injected tirzepatide. Avoid areas with scars, rashes, or bruises.
14. Wipe your skin with your second alcohol wipe. Let it dry.
15. Hold the syringe with the needle facing up, and push down on the plunger just enough for a drop of liquid to form at the end of the needle.
16. Pinch the skin at your injection site (if advised to do so by your prescriber) and quickly push the needle into it, making sure to insert the full length of the needle. Slowly push down on the plunger to inject your full dose, keeping the needle in your skin for at least five seconds.
17. Pull out the needle and discard the syringe in a FDA-cleared sharps disposal container. If you bleed, gently press on the area with a cotton ball or an alcohol swab — don’t rub it.
How to get tirzepatide
Tirzepatide is a prescription medication, so you’ll need to see a healthcare provider in order to get it. Here are the steps you can take to get tirzepatide for weight loss or type 2 diabetes, either online or in-person.
Step 1: Consult a healthcare provider
The first step in getting tirzepatide is making an appointment with a licensed healthcare provider who can write prescriptions. You can meet with your primary care physician (PCP), endocrinologist, or weight loss specialist.
If you prefer, you can also connect with a healthcare provider online through a direct-to-patient healthcare company such as Ro. Direct-to-patient companies offer a convenient way to access medications like tirzepatide, particularly for those who prefer virtual consultations or want to get their medication faster.
During your appointment, your healthcare provider will determine if tirzepatide is the right treatment option for you. Come prepared to share your medical history, current medications and health conditions, and goals for weight loss or type 2 diabetes. (With a company such as Ro, you may answer these questions before your visit via an online questionnaire).
This information helps your provider assess whether tirzepatide is a safe and effective option for you. They may also order lab tests before recommending tirzepatide or another treatment.
If you and your healthcare provider decide tirzepatide is a good option for you to try, they’ll write you a prescription.
Step 2: Verify your insurance coverage
It can be helpful to confirm whether your insurance plan covers tirzepatide before you head to the pharmacy. Some direct-to-patient healthcare companies, including Ro, will connect with your insurance plan on your behalf to determine coverage. Not all insurance plans cover tirzepatide. When they do, prior authorization is typically required.
This means your healthcare provider will need to submit paperwork to your insurance plan showing that you: a) are taking tirzepatide for an FDA-approved condition (e.g., type 2 diabetes in the case of Mounjaro and weight management, or sleep apnea in the case of Zepbound) and b) meet certain criteria.
These criteria can depend on the insurer and which brand name version of tirzepatide you are taking:
For Mounjaro, you will need a diagnosis of type 2 diabetes, with or without a high risk of major cardiovascular problems.
For Zepbound, you will need to have obesity or overweight with a weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes. Or you will need to have obesity and moderate to severe obstructive sleep apnea.
If your insurance doesn’t cover tirzepatide, there are still ways you can save on the cost of tirzepatide. Eli Lilly offers Savings Cards for both Mounjaro and Zepbound that can bring the cost down significantly for eligible individuals. There are also several websites, such as GoodRx, Optum Perks, or SingleCare, that share pharmacy-specific coupons for Zepbound and Mounjaro.
Step 3: Fill your prescription
When you’re ready to fill your prescription, you can either bring it to your preferred pharmacy or have your provider send it electronically.
If you received your prescription through a company like Ro, they’ll handle the process of filling it for you. Many direct-to-patient healthcare companies (including Ro) will ship tirzepatide directly to your home, and some local pharmacies offer home shipping as well.
Bottom line
Tirzepatide (the active ingredient in Mounjaro and Zepbound) is a dual GLP-1 and GIP receptor agonist. This combination enhances insulin release, reduces glucose production, slows gastric emptying, and reduces appetite, making it more effective for weight loss and type 2 diabetes than single GLP-1 receptor agonists like Ozempic and Wegovy.
Tirzepatide works for weight loss by keeping food in the stomach for longer (helping you feel fuller longer), and decreasing appetite, cravings, and food noise in the brain.
Clinical trials showed tirzepatide can produce an average weight loss of 15%–20.9% over 72 weeks.
Tirzepatide is available in prefilled pens or vials. To take tirzepatide, you give yourself a subcutaneous injection once a week. It starts working immediately, but significant weight loss and improved blood sugar control typically become noticeable within the first few months of use.
Tirzepatide has some downsides, including a long list of potential side effects and a high out-of-pocket cost. Many of tirzepatide’s most common side effects, like nausea, diarrhea, and abdominal pain, typically subside over time.
Rare but serious side effects include pancreatitis, gallbladder issues, and kidney problems. It is also expensive, and insurance coverage may vary depending on whether it’s prescribed for type 2 diabetes or weight loss.
Frequently asked questions (FAQs)
What is tirzepatide?
Tirzepatide is the active ingredient in Mounjaro and Zepbound. Both medications are once-weekly injections that cause weight loss. They share the same active ingredient and mechanism of action and come in the same dosage amounts. The key difference between Zepbound and Mounjaro is their approved indications.
The FDA first approved Mounjaro in 2022 as a treatment for type 2 diabetes. As researchers became aware of the drug’s potent weight loss effects, Eli Lilly sought approval for a new indication.
In 2023, the FDA approved Zepbound for weight loss and chronic weight management in people with obesity or overweight plus a weight-related health condition (e.g., high blood pressure or sleep apnea).
In December 2024, the FDA further expanded tirzepatide’s indications, approving Zepbound for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
Both medications are meant to be used in combination with lifestyle changes like diet and exercise.
How does tirzepatide work?
Tirzepatide works by acting on two hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).
GIP and GLP-1 are natural hormones that play key roles in regulating your blood sugar and appetite. After you eat, these hormones prompt the pancreas to stimulate insulin release and signal the liver to reduce glucose production, helping to maintain stable blood sugar levels.
Additionally, they slow the rate at which food moves from the stomach to the small intestine — a process called gastric emptying — and communicate with the brain to create a sense of fullness. These hormones may also help curb cravings and reduce "food noise," the constant preoccupation with food and intrusive thoughts about eating many people struggle with.
The combination of both GLP-1 and GIP in one medication creates a complementary effect that is thought to make tirzepatide more effective for both weight loss and type 2 diabetes than a similar medication, semaglutide, which is the active ingredient in Ozempic and Wegovy.
What are the drawbacks of tirzepatide?
Tirzepatide is an effective medication, but like most prescription medications, it has some downsides to consider. First, it has a long list of possible side effects, which range from nausea and diarrhea to gassiness and hair loss.
Most of the drug’s digestive side effects lessen with time, but they can be intense enough to cause a small number of people to stop taking tirzepatide. And while rare, serious side effects can also occur, including pancreatitis and kidney or gallbladder problems that may or may not be related to the medication.
Tirzepatide can also be expensive, with an out-of-pocket cost upwards of $1,000. Insurance coverage also varies, especially when taken for weight loss. For example, Medicare may not cover weight loss drugs at all (although the temporary GLP-1 Bridge program makes them more affordable at $50 per month for eligible Part D members), and Medicaid coverage can vary by state.
Finally, tirzepatide is meant to be a long-term medication for type 2 diabetes or weight management. This is another potential drawback for some people, especially when you factor in tirzepatide’s side effects and high cost.
It may not necessarily be a lifelong treatment for everyone, so talk to your healthcare provider. There may be ways they can adjust your treatment, according to Dr. Cabandugama. “When I talk to a patient, they give me a goal they want to get to and I check that it’s safe. If they have type 2 diabetes or cardiovascular disease, I give them the option to taper off once they meet that goal,” Dr. Cabandugama says.
What are tirzepatide side effects?
The most common side effects of tirzepatide include:
Nausea
Diarrhea
Vomiting
Constipation
Abdominal pain
Dyspepsia (upset stomach or indigestion)
Injection site reactions (e.g., bruising, pain, itching)
Fatigue
Eructation (belching)
Hair loss
Gastroesophageal reflux disease (GERD) or heartburn
Flatulence
Abdominal distension (bloating)
Dizziness
Hypotension (low blood pressure)
Thankfully, most of tirzepatide’s digestive side effects tend to improve with time as your body gets used to the medication.
In rare cases, tirzepatide can cause more serious side effects, including pancreatitis, kidney or gallbladder problems, severe allergic reactions, pulmonary aspiration during general anesthesia, and hypoglycemia or diabetic retinopathy complications in people with type 2 diabetes.
Can I drink coffee on tirzepatide?
While you can drink coffee on tirzepatide, you may be more likely to experience gastrointestinal side effects if you do so. Caffeine can worsen some of the GI symptoms associated with tirzepatide, including diarrhea and heartburn.
Coffee can also contribute to dehydration, which is already more common with tirzepatide, thanks to fluid-depleting side effects like vomiting, nausea, and diarrhea. If you’re not regularly replenishing your fluids, the dehydration can become so severe that it increases the likelihood of experiencing serious side effects on tirzepatide, including kidney failure.
To prevent serious side effects, make sure to drink plenty of water and other non-caloric fluids slowly and frequently throughout the day. It also helps to learn the signs of dehydration, which include decreased urine output, dizziness, and dry mouth.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Mounjaro Important Safety Information: Read more about serious warnings and safety info.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
Ozempic Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
References
American Diabetes Association (2021). 8. Obesity management for the treatment of type 2 diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care, 44(Suppl 1), S100–S110. doi: 10.2337/dc21-S008. Retrieved from https://diabetesjournals.org/care/article/44/Supplement_1/S100/30970/8-Obesity-Management-for-the-Treatment-of-Type-2
Aronne, L. J., Sattar, N., Horn, D. B., et al. (2024). Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial. JAMA, 331(1), 38–48. doi: 10.1001/jama.2023.24945. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10714284/
Balfour, J. & Boster, J. (2023). Physical activity and weight loss maintenance. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK572051/
Cai, W., Zhang, R., Yao, Y., et al. (2024). Tirzepatide as a novel effective and safe strategy for treating obesity: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Public Health, 12, 1277113. doi: 10.3389/fpubh.2024.1277113. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10864442/
Farzam, K. & Patel, P. (2024). Tirzepatide. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK585056/
Garvey, W. T., Frias, J. P., Jastreboff, A. M., et al. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet (London, England), 402(10402), 613–626. doi: 10.1016/S0140-6736(23)01200-X. Retrieved from https://pubmed.ncbi.nlm.nih.gov/37385275/
Gorgojo-Martínez, J. J., Mezquita-Raya, P., Carretero-Gómez, J., et al. (2022). Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus. Journal of Clinical Medicine, 12(1), 145. doi: 10.3390/jcm12010145. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9821052/
Hall, K. D., Ayuketah, A., Brychta, R., et al. (2019). Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell Metabolism, 30(1), 67–77.e3. doi: 10.1016/j.cmet.2019.05.008. Retrieved from https://www.cell.com/cell-metabolism/fulltext/S1550-4131%2819%2930248-7
Hayashi, D., Edwards, C., Emond, J. A., et al. (2023). What is food noise? A conceptual model of food cue reactivity. Nutrients, 15(22), 4809. doi: 10.3390/nu15224809. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10674813/
Heise, T., DeVries, J. H., Urva, S., et al. (2023). Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes. Diabetes Care, 46(5), 998–1004. doi: 10.2337/dc22-1710. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10154650/
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. The New England Journal of Medicine, 387(3), 205–216. doi: 10.1056/NEJMoa2206038. Retrieved from https://www.nejm.org/doi/10.1056/NEJMoa2206038
Lin, F., Yu, B., Ling, B., et al. (2023). Weight loss efficiency and safety of tirzepatide: A Systematic review. PloS One, 18(5), e0285197. doi: 10.1371/journal.pone.0285197. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10159347/
Rodriguez, P. J., Goodwin Cartwright, B. M., Gratzl, S., et al. (2024). Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity. JAMA Internal Medicine, 184(9), 1056–1064. doi: 10.1001/jamainternmed.2024.2525. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11231910/
Samms, R. J., Coghlan, M. P., & Sloop, K. W. (2020). How may GIP enhance the therapeutic efficacy of GLP-1?. Trends in Endocrinology and Metabolism: TEM, 31(6), 410–421. doi: 10.1016/j.tem.2020.02.006. Retrieved from https://www.cell.com/trends/endocrinology-metabolism/fulltext/S1043-2760(20)30048-5
U.S. Food & Drug Administration (FDA). (2024). FDA Approves First Medication for Obstructive Sleep Apnea. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea
U.S. Food & Drug Administration (FDA). (2023). FDA Approves New Medication for Chronic Weight Management. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management
U.S. Food and Drug Administration (FDA). (2026-a). Highlights of Prescribing Information: Mounjaro (tirzepatide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215866s044s045lbl.pdf
U.S. Food and Drug Administration (FDA). (2026-b). Highlights of Prescribing Information: Zepbound (tirzepatide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s042lbl.pdf
Wadden, T. A., Chao, A. M., Moore, M., et al. (2023). The role of lifestyle modification with second-generation anti-obesity medications: comparisons, questions, and clinical opportunities. Current Obesity Reports, 12(4), 453–473. doi: 10.1007/s13679-023-00534-z. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10748770/















